Two and a half years ago, in 2015, Biotechnology Journal released a special issue on Mammalian Production Systems with an Editorial entitled “On the cusp of rational cell engineering.” This title was chosen to express the expectancy, arising from recent developments such as the release of the CHO and Chinese hamster genomes, to understand in unprecedented detail the molecular and biochemical mechanisms at work in mammalian cell lines used for the production of biopharmaceutics. Since then, we have seen the publication of genome sequences for several more cell lines, of a plethora of transcriptome and proteome datasets and the first exploration of the impact of epigenetics on cellular behavior in bioprocessing, along with the advent of highly efficient and targeted genome editing tools such as CRISPR/Cas9, which have considerably enhanced the scope and speed of cell line engineering.Due to the importance of biopharmaceutics for research, medicine and industry, the European Union realized the urgency of having appropriately trained individuals in their workforce, able to handle the associated multi‐disciplinary challenges. Therefore, an International Training Network on “enhancing CHO by systems biology,” in short eCHO, was established within the EU Marie‐Curie Actions Program, to train 15 PhD students in the diverse
Biotechnology Journal – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera